ArticleMultiple sclerosis journal - experimental, translational and clinical

Patient and treatment characteristics and safety outcomes of patients with relapsing-remitting multiple sclerosis treated with natalizumab in Greece: Results from the multicenter, 5-year prospective observational study 'TOPICS greece'.

Panagiotis Karanasios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.